Jefferies Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-50,500
Closed -$380K – 1988
2023
Q2
$380K Sell
50,500
-49,500
-50% -$401K ﹤0.01% 1262
2023
Q1
$885K Sell
100,000
-260,200
-72% -$2.57M 0.01% 938
2022
Q4
$3.29M Buy
+360,200
New +$3.14M 0.02% 493

Other funds holding TEVA

Jefferies Financial Group's TEVA Position: Q2 2026 in Review

Jefferies Financial Group increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 44% in Q2 2026, buying an estimated $458K and bringing the position to 45,304 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #784.

Jefferies Financial Group first reported a position in TEVA in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.91M in Q4 2022. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Jefferies Financial Group held 45,304 shares of Teva Pharmaceutical Industries Limited worth $1.53M as of Q2 2026.
  • Jefferies Financial Group bought 13,740 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $458K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #784 holding.
  • Jefferies Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2022 and has held it in 8 quarters since.
  • Jefferies Financial Group's Teva Pharmaceutical Industries Limited position peaked at $1.91M in Q4 2022.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.